The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer
Natalie Ludyga(Helmholtz Zentrum München), Michaela Aubele(Helmholtz Zentrum München)
Cited by 53
Related Papers
MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
|British Journal of Cancer|2013|58
Effects of Simultaneous Knockdown of HER2 and PTK6 on Malignancy and Tumor Progression in Human Breast Cancer Cells
|Molecular Cancer Research|2013|23
Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221
|Oncotarget|2015|15